We next identified genes that distinguish the subpopulation of predicted-reactive KIR+CD8+ T cells in the blood and clonally related T cells in the tumor from all other CD8+ T cells in the blood and tumor, respectively. Here, KIR3DL1 is linked to neoplasm.